SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001231919-24-000043
Filing Date
2024-04-16
Accepted
2024-04-16 17:21:59
Documents
1
Effectiveness Date
2024-04-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13833
  Complete submission text file 0001231919-24-000043.txt   15147
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: D | Act: 33 | File No.: 021-510786 | Film No.: 24848754
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)